GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camp4 Therapeutics Corp (NAS:CAMP) » Definitions » Gross Margin %

CAMP (Camp4 Therapeutics) Gross Margin % : 0.00% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Camp4 Therapeutics Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Camp4 Therapeutics's Gross Profit for the three months ended in Jun. 2024 was $0.00 Mil. Camp4 Therapeutics's Revenue for the three months ended in Jun. 2024 was $0.00 Mil. Therefore, Camp4 Therapeutics's Gross Margin % for the quarter that ended in Jun. 2024 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Camp4 Therapeutics's Gross Margin % or its related term are showing as below:


CAMP's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 61.14
* Ranked among companies with meaningful Gross Margin % only.

Camp4 Therapeutics had a gross margin of N/A% for the quarter that ended in Jun. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Camp4 Therapeutics was 0.00% per year.


Camp4 Therapeutics Gross Margin % Historical Data

The historical data trend for Camp4 Therapeutics's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camp4 Therapeutics Gross Margin % Chart

Camp4 Therapeutics Annual Data
Trend Dec22 Dec23
Gross Margin %
- -

Camp4 Therapeutics Quarterly Data
Dec22 Jun23 Dec23 Jun24
Gross Margin % - - - -

Competitive Comparison of Camp4 Therapeutics's Gross Margin %

For the Biotechnology subindustry, Camp4 Therapeutics's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camp4 Therapeutics's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camp4 Therapeutics's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Camp4 Therapeutics's Gross Margin % falls into.



Camp4 Therapeutics Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Camp4 Therapeutics's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=0.4 / 0.35
=(Revenue - Cost of Goods Sold) / Revenue
=(0.35 - 0) / 0.35
=N/A %

Camp4 Therapeutics's Gross Margin for the quarter that ended in Jun. 2024 is calculated as


Gross Margin % (Q: Jun. 2024 )=Gross Profit (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Camp4 Therapeutics  (NAS:CAMP) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Camp4 Therapeutics had a gross margin of N/A% for the quarter that ended in Jun. 2024 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Camp4 Therapeutics Gross Margin % Related Terms

Thank you for viewing the detailed overview of Camp4 Therapeutics's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Camp4 Therapeutics Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
One Kendall Square, Building 1400 West, 3rd Floor, Cambridge, MA, USA
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.

Camp4 Therapeutics Headlines